Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subject

被引:21
作者
Guerrero-Romero, F
Rodríguez-Morán, M
机构
[1] Res Grp Diabet & Chron Illnesses, Durango, Mexico
[2] Mexican Social Secur Inst, Med Res Unit, Durango, Mexico
关键词
metabolic syndrome; C-reactive protein; obesity; dyslipidemia high blood pressure; micoalbuminuria;
D O I
10.1016/S1262-3636(07)70009-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the relationship between CRP levels and the components of MS in normal glucose tolerant (NGT), impaired glucose tolerant (IGT), and Type 2 diabetic subjects. Material and methods: A based cross-sectional population study was performed. Eligible subjects, men and non-pregnant women, 30 to 64 year of age, were randomly recruited. Subjects with acute or chronic diseases were excluded. Only newly diagnosed type 2 diabetic or hypertensive subjects were included. Disorders related to CRP increase, also were exclusion criteria. In accordance to WHO proposal, components of MS were: High Blood Pressure, Dyslipidemia, Obesity, and Microalbuminuria, and MS was defined, for the NGT, if at least two of the criteria were fulfilled and in addition the subject had insulin resistance. The MS in IGT and DM subjects was defined if at least two of the criteria were fulfilled. Results: CRP was significantly associated with MS for the NGT (Odds ratio -OR- 3.8, Cl-95% 1.6-14.8), IGT (OR 4.9, Cl-95%, 1.2-15.5), and diabetes (OR 5.6, Cl-95%, 1.9-10.2). For NGT, after adjustment for obesity, CRP was not longer associated with MS. After adjust for obesity and fasting glucose (FG), the relationship between CRP and MS for IGT was lost. Finally, after adjustment for obesity, FG, and microalbuminuria, CRP was not longer associated with MS for diabetic subjects. Conclusions: This study show a significant relationship between CRP and MS which is maintained only by obesity in the NGT, by obesity and FG in the IGT, and by obesity, FG, and microalbuminuria in the newly diagnosed diabetic subjects.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 49 条
[1]  
ALBERTI KGM, 1998, DIABETIC MED, V5, P53
[2]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[3]  
BAUMANN H, 1990, MOL BIOL MED, V7, P147
[4]   Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects [J].
Blackburn, R ;
Giral, P ;
Bruckert, E ;
André, JM ;
Gonbert, S ;
Bernard, M ;
Chapman, MJ ;
Turpin, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (12) :1962-1968
[5]   ALBUMINURIA REFLECTS WIDESPREAD VASCULAR DAMAGE - THE STENO HYPOTHESIS [J].
DECKERT, T ;
FELDTRASMUSSEN, B ;
BORCHJOHNSEN, K ;
JENSEN, T ;
KOFOEDENEVOLDSEN, A .
DIABETOLOGIA, 1989, 32 (04) :219-226
[6]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[7]   Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes [J].
Ebeling, P ;
Teppo, AM ;
Koistinen, HA ;
Koivisto, VA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (03) :283-287
[8]   PHYSIOLOGICAL AND METABOLIC CONSEQUENCES OF OBESITY [J].
FERRANNINI, E .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (09) :15-17
[9]   HYPERINSULINEMIA - THE KEY FEATURE OF A CARDIOVASCULAR AND METABOLIC SYNDROME [J].
FERRANNINI, E ;
HAFFNER, SM ;
MITCHELL, BD ;
STERN, MP .
DIABETOLOGIA, 1991, 34 (06) :416-422
[10]   Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS) [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
CIRCULATION, 2000, 102 (01) :42-47